Yuan Zhong

Dr. Yuan Zhong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2018 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
YZYuan Zhong
Yuan Zhong
YZYitong Zhu
Yitong Zhu
THTing He
Ting He
WLWei Li
Wei Li
QLQinjie Li
Qinjie Li
YMYa Miao
Ya Miao
It is not known whether brain‑derived neurotrophic factor (BDNF) protects hippocampal neurons from high glucose‑induced apoptosis and/or synaptic plasticity dysfunction. The present study aimed to assess whether BDNF exerted a neuroprotective effect in rat hippocampal neurons exposed to high glucose and examine the underlying mechanisms. The apoptosis of primary hippocampal neurons was assessed by Annexin V‑fluorescein isothiocyanate/propidium iodide staining. The mRNA and protein expression levels were measured by reverse transcription‑­quantitative polymerase chain reaction and western blot experiments, respectively. Synaptic plasticity was evaluated by the immunolocalization of synaptophysin (Syn). Exposure of the hippocampal neurons to high glucose (75 mM for 72 h) resulted in cell apoptosis, decreased mRNA and protein expression levels of three synaptic plasticity‑related proteins (Syn, Arc and cyclic AMP response element‑binding protein), and changes in the cellular distribution of Syn, indicating loss of synaptic density. These effects of high glucose were partially or completely reversed by prior administration of BDNF (50 ng/ml for 24 h). Pre‑treatment with wortmannin, a phosphatidylinositol‑3‑kinase (PI3K) inhibitor, suppressed the ability of BDNF to inhibit the effects of high glucose. In addition, BDNF significantly upregulated the tropomyosin‑related kinase B, its cognate receptor, Akt and phosphorylated Akt at the protein levels under high glucose conditions. In conclusion, high glucose induced apoptosis and downregulated synaptic plasticity‑related proteins in hippocampal neurons. These effects were reversed by BDNF via the PI3K/Akt signaling pathway.

30 July 2019 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
YZYunxia Zhu
Yunxia Zhu
XZXiaoyan Zhang
Xiaoyan Zhang
LZLi Zhang
Li Zhang
MZMingliang Zhang
Mingliang Zhang
LLLing Li
Ling Li
YZYuan Zhong
Yuan Zhong
Chronic exposure of pancreatic β-cells to excess free fatty acids is thought to contribute to type 2 diabetes pathogenesis in obesity by impairing β-cell function and even leading to apoptosis. In β-cells, lipid droplet-associated protein perilipin 5 (PLIN5) has been shown to enhance insulin secretion by regulating intracellular lipid metabolism; the roles of PLIN5 in response to lipotoxicity remain poorly understood. INS-1 β-cells were transfected with PLIN5-overexpression adenovirus (Ad-PLIN5) and treated with palmitate. C57BL/6 J male mice were fed with high fat diet and tail intravenous injected with adeno-associated virus overexpressing PLIN5 (AAV-PLIN5) in β-cells. Our data showed that palmitate and PPAR agonists including WY14643 (PPARα), GW501516 (PPARβ/δ), rosiglitazone (PPARγ) in vitro all induced PLIN5 expression in INS-1 cells. Under palmitate overload, although upregulating PLIN5 promoted lipid droplet storage, it alleviated lipotoxicity in INS-1 β-cells with improved cell viability, cell apoptosis and β-cell function. The protection role of PLIN5 in β-cell function observed in cell experiments were further verified in in vivo study indicated by mitigated glucose intolerance in high fat diet fed mice with β-cell-specific overexpression of PLIN5. Mechanistic experiments revealed that enhanced FAO induced by elevation of PLIN5, followed by decreased ER stress may be a major mechanism responsible for alleviation of lipotoxicity observed in the present study. Our finding substantiated the important role of PLIN5 in protection against lipotoxicity in β-cells.

23 May 2015 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YMYa Miao
Ya Miao
THTing He
Ting He
YZYitong Zhu
Yitong Zhu
WLWei Li
Wei Li
BWBeiyuan Wang
Beiyuan Wang
YZYuan Zhong
Yuan Zhong

1 January 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
YZYuan Zhong
Yuan Zhong
YZYitong Zhu
Yitong Zhu
THTing He
Ting He
WLWei Li
Wei Li
HYHong Yan
Hong Yan
YMYa Miao
Ya Miao

11 January 2020 in Aging
Verified
Journal Article
Open access
DGDonghao Guo
Donghao Guo
YSYun Shen
Yun Shen
WLWei Li
Wei Li
QLQinjie Li
Qinjie Li
YMYa Miao
Ya Miao
YZYuan Zhong
Yuan Zhong
Flavin-containing monooxygenase 3 (FMO3) gene expression is often upregulated in long-lived murine models. However, the specific relationship between FMO3 and aging remains unknown. Here, we show that 40% calorie restriction (CR), which is considered to be one of the most robust interventions to delay aging progression, markedly upregulates FMO3. Most importantly, upregulation of hepatocyte FMO3 in murine models prevented or reversed hepatic aging. Accordingly, the upregulation of FMO3 mimicked the effects of CR: reduced serum levels of pro-inflammatory cytokine interleukin-6 and fasting insulin; relief of oxidative stress, with lower hepatic malondialdehyde levels and higher superoxide dismutase activity; reduced serum and hepatic levels of total cholesterol and triglyceride, as well as reduced lipid deposition in the liver; and diminished levels of aging-related markers β-gal and p16. There were also synergistic effects between FMO3 upregulation and CR. Inhibition of autophagy blocked the anti-aging effects of upregulation of hepatocyte FMO3, including reversing the amelioration of the serum and hepatic parameters related to inflammation, oxidative stress, lipid metabolism, liver function, and hepatocyte senescence. Our results suggest that the upregulation of FMO3 mimics CR to prevent or reverse hepatic aging by promoting autophagy.

7 May 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
YMYa Miao
Ya Miao
DGDonghao Guo
Donghao Guo
WLWei Li
Wei Li
YZYuan Zhong
Yuan Zhong
Recent studies suggest that diabetes predisposes patients to develop neurodegenerative Alzheimer’s disease (AD), although the underlying mechanisms have yet to be determined. Compromised autophagy of neuronal cells, which occurs in the early stages o